These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 187507)

  • 21. Effect of booster vaccination with a multivalent clostridial bacterin-toxoid on sudden death syndrome mortality rate among feedlot cattle.
    De Groot B; Dewey CE; Griffin DD; Perino LJ; Moxley RA; Hahn GL
    J Am Vet Med Assoc; 1997 Sep; 211(6):749-53. PubMed ID: 9301747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified toxin-binding inhibition (ToBI) test for epsilon antitoxin determination in serum of immunized rabbits.
    Sobrinho EM; Cangussu AS; Brandi IV; Sari RS; Almeida AC; Colen F; Quintilio W; Santos HO
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):129-33. PubMed ID: 20709411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitoxin titer in colostrum and milk after vaccination of sows with Clostridium perfringens type C toxoid vaccine.
    Djurickovic SM; Dworak JE; Wickham KL
    Vet Med Small Anim Clin; 1975 Mar; 70(3):283-5. PubMed ID: 164076
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of immune response stimulated in sheep, rabbits and guinea pigs by the administration of multi-component clostridial vaccines.
    Webster AC; Frank CL
    Aust Vet J; 1985 Apr; 62(4):112-4. PubMed ID: 3896219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alternative to the toxin neutralization assay in mice for the potency testing of the Clostridium tetani, Clostridium septicum, Clostridium novyi type B and Clostridium perfringens type D epsilon components of multivalent sheep vaccines.
    Wood KR
    Biologicals; 1991 Oct; 19(4):281-6. PubMed ID: 1797039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and characterization of Clostridium perfringens recombinant β toxoid.
    Milach A; de los Santos JR; Turnes CG; Moreira AN; de Assis RA; Salvarani FM; Lobato FC; Conceição FR
    Anaerobe; 2012 Jun; 18(3):363-5. PubMed ID: 22306065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E; Schulze F; Cussler K; Hänel I; Diller R
    Vet Microbiol; 2006 Apr; 114(1-2):41-50. PubMed ID: 16361070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme linked immunosorbent assay for potency testing of vaccines containing Clostridium perfringens type D epsilon-toxoid.
    Pfahler W; Bisesti E; Pereyra JB; Iribarren F
    Zentralbl Veterinarmed B; 1998 Apr; 45(3):133-9. PubMed ID: 9588107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relative potency of an oily adjuvant multicomponent vaccine in laboratory animals and sheep.
    Thomson RO; Knight PA
    Dev Biol Stand; 1976; 32():265-9. PubMed ID: 1001833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass production and standardization of Clostridium oedematiens vaccine against black disease (infectious necrotic hepatitis) of sheep.
    Ardehali M; Darakhshan H; Moosawi M
    Dev Biol Stand; 1986; 64():137-40. PubMed ID: 3792643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Trials of immunostimulation of an antitoxic response with levamisole in the immunization of sheep with a combined clostridial vaccine].
    Bineva I; Peĭchev B; Marinov MI
    Vet Med Nauki; 1986; 23(4):35-8. PubMed ID: 2874649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation.
    Redhead K; Lucken R; van de Moer A; Houghton S; Simpson B; Cameron A; Monkton P; Hennesy K; Ellis C
    Dev Biol Stand; 1999; 101():261-6. PubMed ID: 10566800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination of turkeys with Clostridium septicum bacterin-toxoid: evaluation of protection against clostridial dermatitis.
    Thachil AJ; McComb B; Kromm M; Nagaraja KV
    Avian Dis; 2013 Jun; 57(2):214-9. PubMed ID: 24689176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
    Luick K; Gottschaldt J; Schulze F; Werner E; Erler W; Borrmann E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):178-82. PubMed ID: 11998370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some observations on the quality control testing of Clostridium chauvoei vaccines.
    Chandler HM
    Dev Biol Stand; 1976; 32():137-41. PubMed ID: 1001827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and standardization of polyvalent Clostridium perfringens vaccine in Iran.
    Ardehali M; Darakhshan H
    Dev Biol Stand; 1976; 32():31-4. PubMed ID: 187509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective immunization of lambs against enterotoxaemia.
    Cameron CM
    Onderstepoort J Vet Res; 1980 Dec; 47(4):287-9. PubMed ID: 7231926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of cattle and sheep with a combined Clostridium perfringens types C and D toxoid.
    Kennedy KK; Norris SJ; Beckenhauer WH; White RG
    Am J Vet Res; 1977 Oct; 38(10):1515-7. PubMed ID: 201186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.